RBL LLC launches Duracyte, advancing living pharmacy platform in Houston’s growing biotech hub
RBL LLC, a pioneering biotech venture creation studio dedicated to rapidly building companies based on breakthrough medical technologies, today announced the launch of Duracyte, a biotechnology company commercializing a pioneering class of implantable “biohybrid pharmacy” devices designed to produce therapeutic proteins continuously inside the human body.
The Center for Innovation and Translation of Point-of-Care Technologies for Expanded Cancer Care Access, a Rice-led collaboration of partners from three continents and based in the Texas Medical Center, has announced its second round of subawardees.
Senior Spotlight 2026: For this aspiring physician, computer science is ‘empowering’ asset
Rice senior Pankti Mehta is channeling her drive to improve how people access and experience health care by combining computer science with hands-on clinical insight.
Solving the oxygen problem in cell-based drug delivery
Rice researchers and collaborators have now successfully integrated solutions to several persistent challenges to implantable drug factories into a single device.
Scalable platform sheds light on how cancer spreads
A new platform makes it easier to study metastasis and sheds light on how cancer clusters survive in the bloodstream when spreading from a primary tumor to other parts of the body.
Rice students design realistic training model to improve uterine cancer biopsy access worldwide
For an interdisciplinary team of Rice undergraduates, improving global women’s health started with a pressing question: What does it take to make an essential cancer diagnostic procedure available worldwide?
Rice psychologists named APS Fellows for advancing research with real-world impact
Two Rice researchers recently named fellows of the Association for Psychological Science, one of the field’s leading international organizations.
In collaboration with the Houston Health Department, the Rice360 Institute for Global Health Technologies recently hosted a two-part Mobile Stroke Unit Advocacy Hack-a-thon, inviting students to help solve one of the most pressing challenges facing this innovative technology.
Brains in society: De Lange Conference explores how neuroscience is shaping the future
Neuroscientists, artists, educators and policymakers gathered at Rice for the De Lange Conference to explore questions at the center of everyday life: how the brain works and what that means for society.
From climate storytelling to AI innovation: Rice researchers take on global challenges at SXSW
At this year’s South by Southwest (SXSW) conference in Austin, Rice researchers explored how to close that gap, whether by rethinking how climate change is communicated or by accelerating scientific discovery through artificial intelligence.
Rice's Omid Veiseh has been awarded a $2.2 million grant from the Gates Foundation to develop implantable cell factory platforms that can deliver therapeutic antibodies over extended periods.
CRISPR-based technique unlocks healing power of mitochondria for heart failure therapy
Rice researchers and collaborators induced heart cells to increase mitochondria production to optimal levels, opening a path toward a new therapy for heart failure.
A team of researchers led by Rice bioengineer Omid Veiseh has been awarded up to $18.2 million in funding from the Advanced Research Projects Agency for Health to develop a first-of-its-kind regenerative treatment aimed at restoring damaged lymphatic vessels and potentially curing lymphedema, a condition that affects more than 10 million Americans.
Rice’s SynthX Center leads up to $18M effort to transform lymphatic imaging
Rice's SynthX Center is leading a new effort to improve how doctors detect and diagnose lymphatic diseases.
Platform to map living brain noninvasively takes next big step
A technology designed to read gene activity in the brain from a simple blood test has now cleared a major translational hurdle.
